Loading...
Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia
The frontline tyrosine kinase inhibitor (TKI) imatinib has revolutionized the treatment of patients with chronic myeloid leukemia (CML). However, drug resistance is the major clinical challenge in the treatment of CML. The Hedgehog (Hh) signaling pathway and autophagy are both related to tumorigenes...
Saved in:
| Published in: | Autophagy |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Taylor & Francis
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4502679/ https://ncbi.nlm.nih.gov/pubmed/25701353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/15548627.2014.994368 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|